Skip to main content
Erschienen in: CardioVascular and Interventional Radiology 6/2019

08.02.2019 | Laboratory Investigation

Does Drug-Eluting Bead TACE Enhance the Local Effect of IRE? Imaging and Histopathological Evaluation in a Porcine Model

verfasst von: Peter Isfort, Philip Rauen, Hong-Sik Na, Nobutake Ito, Saskia von Stillfried, Christiane Kuhl, Philipp Bruners

Erschienen in: CardioVascular and Interventional Radiology | Ausgabe 6/2019

Einloggen, um Zugang zu erhalten

Abstract

Objectives

We conducted an in vivo trial on swine to compare the ablation volumes of irreversible electroporation (IRE) followed by drug-eluting beads transarterial chemoembolization (DEB-TACE) versus IRE only.

Materials and Methods

Nine swine underwent CT-guided IRE in one liver lobe and IRE immediately followed by DEB-TACE in a different liver lobe. For DEB-TACE, 100–300 µm beads (DC-Beads®) were loaded with 50 mg doxorubicin. For IRE, the NanoKnife® was used employing two electrodes according to the vendor’s protocol. Imaging follow-up was performed including CT-based lesion volume assessment using contrast-enhanced CT (venous phase) on days 1, 3, and 7 after the procedure. Three animals were killed for histopathological analysis after each follow-up.

Results

Ablation volumes in CT in the IRE + DEB-TACE group were 15.4 ± 10.5 ml on day 1, 8.7 ± 5.6 ml on day 3, and 1.6 ± 0.7 ml on day 7. In the IRE group, the corresponding values were 5.2 ± 5.2 ml on day 1, 1.0 ± 1.2 ml on day 3, and 0.1 ± 0.1 ml on day 7. On day 1 and day 3, ablation volumes of IRE + TACE group were significantly larger than in the IRE group (p < 0.05). 96% of beads were depicted in or around ablative lesions. 69% of these beads were found in the surrounding hemorrhagic infiltration and 31% within the ablative lesion itself.

Conclusions

Combination of IRE immediately followed by DEB-TACE resulted in larger ablation volumes compared to IRE alone, suggesting that local efficacy of IRE can be enhanced by post-IRE DEB-TACE.
Literatur
1.
Zurück zum Zitat Bower M, Sherwood L, Li Y, Martin R. Irreversible electroporation of the pancreas: definitive local therapy without systemic effects. J Surg Oncol. 2011;104(1):22–8.CrossRefPubMed Bower M, Sherwood L, Li Y, Martin R. Irreversible electroporation of the pancreas: definitive local therapy without systemic effects. J Surg Oncol. 2011;104(1):22–8.CrossRefPubMed
2.
Zurück zum Zitat Perera M, Krishnananthan N, Lindner U, Lawrentschuk N. An update on focal therapy for prostate cancer. Nat Rev Urol. 2016;13(11):641–53.CrossRef Perera M, Krishnananthan N, Lindner U, Lawrentschuk N. An update on focal therapy for prostate cancer. Nat Rev Urol. 2016;13(11):641–53.CrossRef
3.
Zurück zum Zitat Niessen C, Igl J, Pregler B, et al. Factors associated with short-term local recurrence of liver cancer after percutaneous ablation using irreversible electroporation: a prospective single-center study. J Vasc Interv Radiol. 2015;26(5):694–702.CrossRefPubMed Niessen C, Igl J, Pregler B, et al. Factors associated with short-term local recurrence of liver cancer after percutaneous ablation using irreversible electroporation: a prospective single-center study. J Vasc Interv Radiol. 2015;26(5):694–702.CrossRefPubMed
4.
Zurück zum Zitat Dollinger M, Jung EM, Beyer L, et al. Irreversible electroporation ablation of malignant hepatic tumors: subacute and follow-up CT appearance of ablation zones. J Vasc Interv Radiol. 2014;25(10):1589–94.CrossRefPubMed Dollinger M, Jung EM, Beyer L, et al. Irreversible electroporation ablation of malignant hepatic tumors: subacute and follow-up CT appearance of ablation zones. J Vasc Interv Radiol. 2014;25(10):1589–94.CrossRefPubMed
5.
Zurück zum Zitat Chung DJ, Sung K, Osuagwu FC, Wu HH, Lassman C, Lu DS. Contrast enhancement patterns after irreversible electroporation: experimental study of CT perfusion correlated to histopathology in normal porcine liver. J Vasc Interv Radiol. 2016;27(1):104–11.CrossRefPubMed Chung DJ, Sung K, Osuagwu FC, Wu HH, Lassman C, Lu DS. Contrast enhancement patterns after irreversible electroporation: experimental study of CT perfusion correlated to histopathology in normal porcine liver. J Vasc Interv Radiol. 2016;27(1):104–11.CrossRefPubMed
6.
Zurück zum Zitat Davalos RV, Mir IL, Rubinsky B. Tissue ablation with irreversible electroporation. Ann Biomed Eng. 2005;33(2):223–31.CrossRefPubMed Davalos RV, Mir IL, Rubinsky B. Tissue ablation with irreversible electroporation. Ann Biomed Eng. 2005;33(2):223–31.CrossRefPubMed
7.
Zurück zum Zitat Kotnik T, Frey W, Sack M, Haberl Meglic S, Peterka M, Miklavcic D. Electroporation-based applications in biotechnology. Trends Biotechnol. 2015;33(8):480–8.CrossRef Kotnik T, Frey W, Sack M, Haberl Meglic S, Peterka M, Miklavcic D. Electroporation-based applications in biotechnology. Trends Biotechnol. 2015;33(8):480–8.CrossRef
8.
Zurück zum Zitat Lammer J, Malagari K, Vogl T, et al. Prospective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION V study. Cardiovasc Intervent Radiol. 2010;33(1):41–52.CrossRef Lammer J, Malagari K, Vogl T, et al. Prospective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION V study. Cardiovasc Intervent Radiol. 2010;33(1):41–52.CrossRef
9.
Zurück zum Zitat Ni JY, Liu SS, Xu LF, Sun HL, Chen YT. Transarterial chemoembolization combined with percutaneous radiofrequency ablation versus TACE and PRFA monotherapy in the treatment for hepatocellular carcinoma: a meta-analysis. J Cancer Res Clin Oncol. 2013;139(4):653–9.CrossRefPubMed Ni JY, Liu SS, Xu LF, Sun HL, Chen YT. Transarterial chemoembolization combined with percutaneous radiofrequency ablation versus TACE and PRFA monotherapy in the treatment for hepatocellular carcinoma: a meta-analysis. J Cancer Res Clin Oncol. 2013;139(4):653–9.CrossRefPubMed
10.
Zurück zum Zitat Dev SBRD, Widera G, Hofmann GA. Medical applications of electroporation. IEEE Trans Plasma Sci. 2000;28(1):206–23.CrossRef Dev SBRD, Widera G, Hofmann GA. Medical applications of electroporation. IEEE Trans Plasma Sci. 2000;28(1):206–23.CrossRef
11.
Zurück zum Zitat Vollherbst D, Bertheau RC, Fritz S, et al. Electrochemical effects after transarterial chemoembolization in combination with percutaneous irreversible electroporation: observations in an acute porcine liver model. J Vasc Interv Radiol. 2016;27(6):913–21.CrossRefPubMed Vollherbst D, Bertheau RC, Fritz S, et al. Electrochemical effects after transarterial chemoembolization in combination with percutaneous irreversible electroporation: observations in an acute porcine liver model. J Vasc Interv Radiol. 2016;27(6):913–21.CrossRefPubMed
12.
Zurück zum Zitat Lee EW, Chen C, Prieto VE, Dry SM, Loh CT, Kee ST. Advanced hepatic ablation technique for creating complete cell death: irreversible electroporation. Radiology. 2010;255(2):426–33.CrossRefPubMed Lee EW, Chen C, Prieto VE, Dry SM, Loh CT, Kee ST. Advanced hepatic ablation technique for creating complete cell death: irreversible electroporation. Radiology. 2010;255(2):426–33.CrossRefPubMed
13.
Zurück zum Zitat Lee EW, Wong D, Tafti BA, et al. Irreversible electroporation in eradication of rabbit VX2 liver tumor. J Vasc Interv Radiol. 2012;23(6):833–40.CrossRefPubMed Lee EW, Wong D, Tafti BA, et al. Irreversible electroporation in eradication of rabbit VX2 liver tumor. J Vasc Interv Radiol. 2012;23(6):833–40.CrossRefPubMed
14.
Zurück zum Zitat Appelbaum L, Ben-David E, Sosna J, Nissenbaum Y, Goldberg SN. US findings after irreversible electroporation ablation: radiologic-pathologic correlation. Radiology. 2012;262(1):117–25.CrossRefPubMed Appelbaum L, Ben-David E, Sosna J, Nissenbaum Y, Goldberg SN. US findings after irreversible electroporation ablation: radiologic-pathologic correlation. Radiology. 2012;262(1):117–25.CrossRefPubMed
Metadaten
Titel
Does Drug-Eluting Bead TACE Enhance the Local Effect of IRE? Imaging and Histopathological Evaluation in a Porcine Model
verfasst von
Peter Isfort
Philip Rauen
Hong-Sik Na
Nobutake Ito
Saskia von Stillfried
Christiane Kuhl
Philipp Bruners
Publikationsdatum
08.02.2019
Verlag
Springer US
Erschienen in
CardioVascular and Interventional Radiology / Ausgabe 6/2019
Print ISSN: 0174-1551
Elektronische ISSN: 1432-086X
DOI
https://doi.org/10.1007/s00270-019-02181-1

Weitere Artikel der Ausgabe 6/2019

CardioVascular and Interventional Radiology 6/2019 Zur Ausgabe

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.